Healthcare >> CEO Interviews >> December 18, 2000
ARTHUR T. SANDS, MD, PhD, founded Lexicon Genetics Incorporated and has
been its President, Chief Executive Officer and a Director since
September 1995. Prior to founding Lexicon, Dr. Sands served as an
American Cancer Society postdoctoral fellow in the Department of Human
and Molecular Genetics at Baylor College of Medicine, where he studied
the function of the p53 gene in cancer formation and created the XPC
knockout mouse, a model for skin cancer. He received his BA in Economics
and Political Science from Yale University and his MD and PhD from
Baylor College of Medicine. Profile
Dr. Sands: Lexicon Genetics Incorporated is a genomics-based drug
discovery company that uses information on how human genes work to
